UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy and Safety of Ceftazidime-Avibactam Plus Metronidazole Versus Meropenem in the Treatment of Complicated Intra-abdominal Infection: Results From a Randomized, Controlled, Double-Blind, Phase 3 Program

Clinical infectious diseases, 2016-06, Vol.62 (11), p.1380-1389

2016

Volltextzugriff (PDF)

Symptomatic Pneumonitis With Durvalumab After Concurrent Chemoradiotherapy in Unresectable Stage III NSCLC

JTO clinical and research reports, 2024-03, Vol.5 (3), p.100638-100638, Article 100638

2024

Volltextzugriff (PDF)

Clinical activity of ceftazidime/avibactam against MDR Enterobacteriaceae and Pseudomonas aeruginosa: pooled data from the ceftazidime/avibactam Phase III clinical trial programme

Journal of antimicrobial chemotherapy, 2018-09, Vol.73 (9), p.2519-2523

2018

Volltextzugriff (PDF)

LATIFY: Phase 3 study of ceralasertib + durvalumab vs docetaxel in patients with locally advanced or metastatic non-small-cell lung cancer that progressed on or after anti-PD-(L)1 and platinum-based therapy

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.TPS9161-TPS9161

2023

Volltextzugriff (PDF)

Safety Profile of Ceftazidime–Avibactam: Pooled Data from the Adult Phase II and Phase III Clinical Trial Programme

Drug safety, 2020-08, Vol.43 (8), p.751-766

2020

Volltextzugriff (PDF)

Safety and Efficacy of Ceftazidime-Avibactam Plus Metronidazole in the Treatment of Children ≥3 Months to <18 Years With Complicated Intra-Abdominal Infection: Results From a Phase 2, Randomized, Controlled Trial

The Pediatric infectious disease journal, 2019-08, Vol.38 (8), p.816-824

2019

Volltextzugriff (PDF)

Safety and Efficacy of Ceftazidime-Avibactam in the Treatment of Children ≥3 Months to <18 Years With Complicated Urinary Tract Infection: Results from a Phase 2 Randomized, Controlled Trial

The Pediatric infectious disease journal, 2019-09, Vol.38 (9), p.920-928

2019

Volltextzugriff (PDF)

The Determinants of Dying Where We Choose: An Analysis of Coordinate My Care

Annals of internal medicine, 2017-10, Vol.167 (7), p.519

2017

Volltextzugriff (PDF)

Impact of prior chemoradiotherapy-related variables on outcomes with durvalumab in unresectable Stage III NSCLC (PACIFIC)

Lung cancer (Amsterdam, Netherlands), 2021-01, Vol.151, p.30-38

2021

Volltextzugriff (PDF)

Characterizing immune-mediated adverse events with durvalumab in patients with unresectable stage III NSCLC: A post-hoc analysis of the PACIFIC trial

Lung cancer (Amsterdam, Netherlands), 2022-04, Vol.166, p.84-93

2022

Volltextzugriff (PDF)

Ceftazidime-Avibactam Susceptibility Breakpoints against Enterobacteriaceae and Pseudomonas aeruginosa

Antimicrobial agents and chemotherapy, 2018-11, Vol.62 (11)

2018

Volltextzugriff (PDF)

Non-pneumonitis immune-mediated adverse events (imAEs) with durvalumab in patients with unresectable stage III NSCLC (PACIFIC)

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.9048-9048

2020

Volltextzugriff (PDF)

Safety, local tolerability and pharmacokinetics of ceftaroline fosamil administered in a reduced infusion volume

British journal of clinical pharmacology, 2014-12, Vol.78 (6), p.1291-1297

2014

Volltextzugriff (PDF)

Advance care planning: the impact of Ceiling of Treatment plans in patients with Coordinate My Care

BMJ supportive & palliative care, 2019-09, Vol.9 (3), p.267-270

2019

Volltextzugriff (PDF)

EN2-4. LATIFY : Phase 3 study of ceralasertib + durvalumab in previously treated locally advanced / metastatic NSCLC

Japanese Journal of Lung Cancer, 2023-10, Vol.63 (5), p.428-428

2023

Volltextzugriff (PDF)

First-line durvalumab plus platinum-etoposide in extensive-stage (ES)-SCLC (CASPIAN): Impact of brain metastases on treatment patterns and outcomes

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.9068-9068

2020

Volltextzugriff (PDF)

Abstract CT024: Durvalumab (D) + platinum-etoposide (EP) in 1L extensive-stage small-cell lung cancer (ES-SCLC): Exploratory analysis of SCLC molecular subtypes in CASPIAN

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.CT024-CT024

2022

Volltextzugriff (PDF)

Abstract 18343: B-type Natriuretic Peptide (BNP) Levels Correlate With Indices of Left Ventricular Function and Predict Outcomes Following Transcatheter Aortic Valve Implantation (TAVI): A Cardiovascular Magnetic Resonance Imaging Study

Circulation (New York, N.Y.), 2015-11, Vol.132 (Suppl_3 Suppl 3), p.A18343-A18343

2015

Volltextzugriff (PDF)

Efficacy of Ceftazidime-Avibactam against Multi-Drug Resistant Enterobacteriaceae and Pseudomonas aeruginosa from the Phase 3 Clinical Trial Program

Open forum infectious diseases, 2016-12, Vol.3 (suppl_1)

2016

Volltextzugriff (PDF)

Out from under the Roof

Childhood education, 1957-01, Vol.34 (1), p.411

Broadhurst, Helen M

1957

Volltextzugriff (PDF)

Out from under the Roof

Childhood education, 1958-05, Vol.34 (9), p.411-412

Broadhurst, Helen M.

1958

Volltextzugriff (PDF)

Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy

Chemical Society reviews, 2011-01, Vol.4 (1), p.387-426

2011

Volltextzugriff (PDF)

Loss of the extraembryonic ectoderm in Elf5 mutants leads to defects in embryonic patterning

Development (Cambridge), 2005-05, Vol.132 (10), p.2299-2308

2005

Volltextzugriff (PDF)

Evaluating the crystalline orbital hierarchy and high-pressure structure-property response of an extended-ligand platinum() bis(1,2-dioximato) complex

CrystEngComm, 2021-09, Vol.23 (36), p.6359-6364

2021

Volltextzugriff (PDF)

Metabolic fingerprinting of salt-stressed tomatoes

Phytochemistry (Oxford), 2003-03, Vol.62 (6), p.919-928

2003

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(29)

Publikationsform

Sprache

Englisch
(35)
Japanisch
(1)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Efficacy and Safety of Ceftazidime-Avibactam Plus Metronidazole Versus Meropenem in the Treatment of Complicated Intra-abdominal Infection: Results From a Randomized, Controlled, Double-Blind, Phase 3 Program

Symptomatic Pneumonitis With Durvalumab After Concurrent Chemoradiotherapy in Unresectable Stage III NSCLC

Clinical activity of ceftazidime/avibactam against MDR Enterobacteriaceae and Pseudomonas aeruginosa: pooled data from the ceftazidime/avibactam Phase III clinical trial programme

LATIFY: Phase 3 study of ceralasertib + durvalumab vs docetaxel in patients with locally advanced or metastatic non-small-cell lung cancer that progressed on or after anti-PD-(L)1 and platinum-based therapy

Safety Profile of Ceftazidime–Avibactam: Pooled Data from the Adult Phase II and Phase III Clinical Trial Programme

Safety and Efficacy of Ceftazidime-Avibactam Plus Metronidazole in the Treatment of Children ≥3 Months to <18 Years With Complicated Intra-Abdominal Infection: Results From a Phase 2, Randomized, Controlled Trial

Safety and Efficacy of Ceftazidime-Avibactam in the Treatment of Children ≥3 Months to <18 Years With Complicated Urinary Tract Infection: Results from a Phase 2 Randomized, Controlled Trial

The Determinants of Dying Where We Choose: An Analysis of Coordinate My Care

Impact of prior chemoradiotherapy-related variables on outcomes with durvalumab in unresectable Stage III NSCLC (PACIFIC)

Characterizing immune-mediated adverse events with durvalumab in patients with unresectable stage III NSCLC: A post-hoc analysis of the PACIFIC trial

Ceftazidime-Avibactam Susceptibility Breakpoints against Enterobacteriaceae and Pseudomonas aeruginosa

Non-pneumonitis immune-mediated adverse events (imAEs) with durvalumab in patients with unresectable stage III NSCLC (PACIFIC)

Safety, local tolerability and pharmacokinetics of ceftaroline fosamil administered in a reduced infusion volume

Advance care planning: the impact of Ceiling of Treatment plans in patients with Coordinate My Care

EN2-4. LATIFY : Phase 3 study of ceralasertib + durvalumab in previously treated locally advanced / metastatic NSCLC

First-line durvalumab plus platinum-etoposide in extensive-stage (ES)-SCLC (CASPIAN): Impact of brain metastases on treatment patterns and outcomes

Abstract CT024: Durvalumab (D) + platinum-etoposide (EP) in 1L extensive-stage small-cell lung cancer (ES-SCLC): Exploratory analysis of SCLC molecular subtypes in CASPIAN

Abstract 18343: B-type Natriuretic Peptide (BNP) Levels Correlate With Indices of Left Ventricular Function and Predict Outcomes Following Transcatheter Aortic Valve Implantation (TAVI): A Cardiovascular Magnetic Resonance Imaging Study

Efficacy of Ceftazidime-Avibactam against Multi-Drug Resistant Enterobacteriaceae and Pseudomonas aeruginosa from the Phase 3 Clinical Trial Program

Out from under the Roof

Out from under the Roof

Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy

Loss of the extraembryonic ectoderm in Elf5 mutants leads to defects in embryonic patterning

Evaluating the crystalline orbital hierarchy and high-pressure structure-property response of an extended-ligand platinum() bis(1,2-dioximato) complex

Metabolic fingerprinting of salt-stressed tomatoes

Suchergebnisse filtern